You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA249
  • Published:  15 March 2012
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive Appendix B: proposal paper presented to the Institute's Guidance Executive
04 February 2013
(632.06 Kb 4 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 30 January 2013

Back to top